The PEERLESS Study
The Peerless Study
Sponsor: Inari Medical
Enrolling: Male and Female Patients
IRB Number: AAAU0351
U.S. Govt. ID: NCT05111613
Contact: Kate Dalton: 347-514-3366 / keb2114@cumc.columbia.edu
Additional Study Information: This study is a prospective, multicenter, randomized controlled trial of the FlowTriever System compared to Catheter-Directed Thrombolysis (CDT) for acute intermediate-high-risk pulmonary embolism (PE), and includes a non-randomized cohort of up to 150 subjects with an absolute contraindication to thrombolytics
This study is closed
Investigator
Sanjum Sethi, MD, MPH
Do You Qualify?
Are you 18 years or older? Yes No
Submit
Cancel
You may be eligible for this study

Place Holder



Cancel
For more information, please contact:
Kate Dalton
keb2114@cumc.columbia.edu
347-514-3366
This website uses cookies as well as similar tools and technologies to understand visitors’ experiences. By continuing to use this website, you consent to Columbia University’s usage of cookies and similar technologies, in accordance with the Columbia University Website Cookie Notice.
I AGREE